Literature DB >> 15238766

Tracking the killers: how should we measure CD8 T cells in HIV infection?

Judy Lieberman1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15238766     DOI： 10.1097/01.aids.0000131320.75396.4d

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  8 in total

Review 1.  The spread, treatment, and prevention of HIV-1: evolution of a global pandemic.

Authors:  Myron S Cohen; Nick Hellmann; Jay A Levy; Kevin DeCock; Joep Lange
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

2.  Autologous CD4/CD8 co-culture assay: a physiologically-relevant composite measure of CD8+ T lymphocyte function in HIV-infected persons.

Authors:  Steven R Fauce; Otto O Yang; Rita B Effros
Journal:  J Immunol Methods       Date:  2007-08-08       Impact factor: 2.303

3.  Immune escape mutations detected within HIV-1 epitopes associated with viral control during treatment interruption.

Authors:  Becky Schweighardt; Terri Wrin; Duncan A Meiklejohn; Gerald Spotts; Christos J Petropoulos; Douglas F Nixon; Frederick M Hecht
Journal:  J Acquir Immune Defic Syndr       Date:  2010-01       Impact factor: 3.731

4.  Fluorescent dye labeled influenza virus mainly infects innate immune cells and activated lymphocytes and can be used in cell-mediated immune response assay.

Authors:  Dongxu Xie
Journal:  J Immunol Methods       Date:  2009-03-31       Impact factor: 2.303

5.  Measuring inhibition of HIV replication by ex vivo CD8⁺ T cells.

Authors:  Chloe K Slichter; David P Friedrich; Rebecca J Smith; Paula N Walsh; Greg Mize; Julie L Czartoski; M Juliana McElrath; Nicole Frahm
Journal:  J Immunol Methods       Date:  2013-12-25       Impact factor: 2.303

6.  Immune and viral correlates of "secondary viral control" after treatment interruption in chronically HIV-1 infected patients.

Authors:  Ellen Van Gulck; Lotte Bracke; Leo Heyndrickx; Sandra Coppens; Derek Atkinson; Céline Merlin; Alexander Pasternak; Eric Florence; Guido Vanham
Journal:  PLoS One       Date:  2012-05-30       Impact factor: 3.240

Review 7.  The Significance of Interferon-γ in HIV-1 Pathogenesis, Therapy, and Prophylaxis.

Authors:  Shannon R Roff; Ezra N Noon-Song; Janet K Yamamoto
Journal:  Front Immunol       Date:  2014-01-13       Impact factor: 7.561

8.  Development of a luciferase based viral inhibition assay to evaluate vaccine induced CD8 T-cell responses.

Authors:  Marloes A Naarding; Natalia Fernandez; John C Kappes; Peter Hayes; Tina Ahmed; Mert Icyuz; Tara G Edmonds; Philip Bergin; Omu Anzala; Tomas Hanke; Lorna Clark; Josephine H Cox; Emmanuel Cormier; Christina Ochsenbauer; Jill Gilmour
Journal:  J Immunol Methods       Date:  2013-11-28       Impact factor: 2.303
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.